Rockwell Medical, Inc. (RMTI)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Rockwell Medical, Inc. (RMTI) is down 19.7% since the beginning of the year. At $1 per share, RMTI is trading 68.1% below its 52-week high of $2. Investors who bought $1,000 worth of RMTI shares 5 years ago would now be looking at an investment worth $70.

Rockwell Medical, Inc. (RMTI) has returned -19.71% so far this year and -24.81% over the past 12 months. Over the last ten years, RMTI has returned -38.07% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Jan 27, 1998, RMTI's average daily return is +0.10%, while the average monthly return is +0.99%. At this rate, an investment would double in approximately 5.9 years.

Historically, 45% of months were positive and 55% were negative. The best month was Sep 2013 with a return of +106.2%, while the worst month was Feb 1998 at -60.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, RMTI closed higher 45% of trading days. The best single day was Mar 20, 2001 with a return of +100.0%, while the worst single day was Nov 12, 2024 at -39.1%.

Rockwell Medical, Inc. has an annualized alpha of 20.20%, beta of 0.69, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since January 27, 1998.

• This stock participated in 147.45% of S&P 500 Index downside but only 51.83% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.69 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

RMTI ranks 32 for risk / return — below 32% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Rockwell Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Rockwell Medical, Inc. was 99.70%, occurring on Jun 11, 2026. The portfolio has not yet recovered.

The current Rockwell Medical, Inc. drawdown is 99.67%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Rockwell Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Rockwell Medical, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.